Filing Summary: Form 10-Q for Quarter Ended September 30, 2021
Issuer discrepancy: The request identifies Firefly Neuroscience, Inc., but the supplied filing is for Information Analysis Incorporated (IAI). The financial information below summarizes the filing provided, not a Firefly Neuroscience filing.
Business Context and Reporting Period
IAI provides IT services and software primarily to U.S. government customers, including system modernization, cloud services, and cybersecurity. This unaudited Form 10-Q covers the three and nine months ended September 30, 2021. Results include Tellenger, acquired April 7, 2021, from that date onward. The filing states IAI operates in one business segment.
Financial Results and Liquidity
- Third-quarter revenue: $4.30 million, up 9.6% year over year. Professional fees rose 77.0% to $2.80 million; software sales fell 35.9% to $1.50 million.
- Third-quarter profitability: Gross profit was $978,875, with a 22.8% gross margin versus 15.7%. Operating loss was $84,267, compared with operating income of $214,906; net loss was $95,527, or $0.01 per share, versus net income of $214,703, or $0.02 per share.
- Nine-month results: Revenue was $12.45 million, up 15.2%; gross profit was $2.95 million, with a 23.7% margin versus 11.9%. Operating income was $238,583 versus $52,850, and net income was $218,445 versus $53,744. Diluted EPS was $0.02 versus approximately break-even.
- Cash flow: Nine-month operating cash flow was negative $425,810, versus positive $38,569 in 2020. Investing cash outflow was $2.29 million, including $2.23 million for Tellenger. Financing cash inflow was $4.54 million, including equity proceeds.
- Cash and liquidity: Cash was $3.68 million at September 30, versus $1.86 million at year-end 2020. Current assets were $6.85 million and current liabilities $3.12 million. Management said cash and its operating plan should meet requirements for at least one year from the filing date; no material capital expenditure commitments were reported.
- Debt: The company reported $1.20 million of notes payable and $402,306 drawn on a $1.0 million revolving credit line. The term loan carries a 4.89% fixed rate; the line rate was 3.25% and expires April 16, 2022, with $597,694 reported available at quarter-end. Notes and the line together totaled approximately $1.60 million.
Material Changes and Unusual Items
- Tellenger expanded IAI’s cybersecurity, cloud, and data analytics capabilities. The preliminary purchase accounting recorded $1.49 million of identifiable intangible assets and $785,000 of goodwill. Acquisition costs were $192,530 for the nine months.
- Revenue mix shifted toward professional services, which had higher reported gross margins than software sales. For the nine months, professional-fee gross margin was 33.5%, while software sales gross margin was 2.2%.
- SG&A increased by $658,102 in the quarter and $1.30 million for the nine months, reflecting added Tellenger administration, acquisition-related intangible amortization, compensation, management and board costs, investor relations, legal expenses, and investment in business development and accounting.
- In August, IAI raised $2.8 million in a private placement of 1.4 million units at $2.00 each; each unit included a share and a warrant exercisable at $3.00. The offering and option exercises increased shares outstanding; 13,510,690 shares were outstanding October 28, 2021.
- At quarter-end, contract liabilities were $78,045, down from $946,884 at year-end. The company said a previously withheld subcontract amount became billable after a prime-contractor deliverable was met.
Outlook, Commentary, and Risks
- Management’s strategy is to grow organically and through acquisitions, expand business development, pursue more prime-contract bids, and build on Tellenger’s capabilities. The filing provides no quantified revenue or earnings guidance.
- Management reported that COVID-19’s effect on existing business had been minimal to date, while noting potential procurement delays, suspended work, payment delays, and constraints on in-person business development; the longer-term impact remained uncertain.
- Revenue and profit depend materially on a small number of subcontracts: three represented 54.4% of third-quarter revenue and 87.9% of gross profit. Two subcontracts tied to one prime contractor and federal agency accounted for 63% of receivables.
- Other stated risks include contract concentration, federal funding changes, competition, hiring and retention, contract-cost estimates, acquisition integration, cybersecurity and IT disruptions, capital access, and the limited public market for the shares.
- The bank approved forgiveness of the full $450,000 PPP loan on October 6, 2021, and submitted the package to the SBA for final approval; resolution was expected in fourth-quarter 2021. The filing also disclosed an October 2021, 36-month Annapolis office lease with initial monthly rent of $12,713.
- Management said disclosure controls were effective. Tellenger had insufficient and limited controls before acquisition; IAI reconstructed its prior financial statements and integrated its books into IAI’s controls, with migration to IAI’s main accounting system planned by early 2022. No legal proceedings or material changes to previously disclosed risk factors were reported.
Important Facts for Investors to Verify
- Confirm the correct issuer: the supplied filing is Information Analysis Incorporated, not Firefly Neuroscience, Inc.
- Assess sustainability of the shift toward professional-services revenue and the very high gross-profit concentration in three subcontracts.
- Review operating cash consumption, receivable concentration and collections, and the effect of contract-liability reductions on cash flow.
- Confirm final SBA approval of PPP forgiveness and monitor scheduled debt payments, revolver renewal or repayment, and borrowing-base availability.
- Track Tellenger integration, acquisition accounting finalization, goodwill and intangible-asset impairment testing, and the planned accounting-system migration.
- Evaluate dilution from the private placement, warrants, and outstanding options, along with any subsequent listing developments; the filing described a pending Nasdaq Capital Market application.